...
首页> 外文期刊>Nigerian Medical Journal >Risk factors and drug-resistance patterns among pulmonary tuberculosis patients in northern Karnataka region, India
【24h】

Risk factors and drug-resistance patterns among pulmonary tuberculosis patients in northern Karnataka region, India

机译:印度卡纳塔克邦北部地区肺结核患者的危险因素和耐药模式

获取原文
           

摘要

Background:India is one of the high tuberculosis (TB)-burden countries in the world. Resistance to anti-tuberculosis (anti-TB) drugs has already become an important and alarming threat in most of the regions worldwide. India ranks second in the world in harbouring multi-drug resistant cases (MDRTB). Prevalence of MDR-TB mirrors the functional state and efficacy of TB control programmes and realistic attitude of the community towards implementation of such programmes. The most important risk factor in the development of MDRTB is improper implementation in the guidelines in the management of TB, and high rate of defaults on the part of the patients. The study was carried out to evaluate the drug resistance pattern to first line anti-TB drugs in Northern Karnataka region, India.Materials and Methods:A prospective study was conducted at J. N. Medical College and its associated Hospitals, Belgaum. Between January 2011 and December 2012, 150 sputum samples of suspected pulmonary TB patients based on the history were examined for the AFB culture by Lowenstein-Jensen (LJ) culture technique. A total of two early morning samples were collected for the smear [Ziehl-Neelsen (ZN) staining] and culture methods. It was observed that ZN staining for AFB was positive in 113 patients (75%), while AFB culture by LJ medium yielded growth in 66 cases (44%). Thus, a total of 66 AFB culture-positive samples by LJ medium were subjected for AFB drug-sensitivity testing (DST). DST was done for Isoniazid (INH), Rifampicin (RIF), Pyrazinamide (PZA), Ethambutol (EMB) and Streptomycin (SM) after isolation by using the resistance proportion method.Results:A total of 66 AFB culture-positive specimens, 20 (30.3%) cases were sensitive to all the five drugs while 46 (69.7%) cases showed resistance to one or more drugs. Among these, the resistance to rifampicin was highest (80.4%), while resistance to isoniazid, pyrazinamide, ethambutol and streptomycin were observed to be 60%, 58.7%, 52.1% and 63%, respectively. It was also observed that, resistance to all five drugs was highest (39.18%). MDR isolates were obtained in 52.2% of the cases. Illiteracy, low socio-economic status, previous history of TB and alcoholism were found to have statistically significant association for the development of MDR.Conclusions:The prevalence of drug resistance in the present study was observed to be 69.7%. More than half of the cases were multi-drug resistant. The most common resistant pattern observed in this study was resistance to all the first-line drugs. Therefore, during initiation of new case proper explaining and completion of the treatment is very important to avoid the development of future drug resistance in the society.
机译:背景:印度是世界上结核病高发国家之一。在全球大多数地区,抗结核药物的耐药性已成为重要且令人震惊的威胁。印度在携带多药耐药病例(MDRTB)方面居世界第二位。耐多药结核病的流行反映了结核病控制计划的功能状态和功效,以及社区对实施此类计划的现实态度。 MDRTB发展中最重要的风险因素是结核病管理指南中实施不当,以及部分患者违约率高。该研究旨在评估印度北部卡纳塔克邦北部地区对一线抗结核药物的耐药模式。材料与方法:前瞻性研究在J. N.医学院及其附属医院Belgaum进行。在2011年1月至2012年12月之间,通过Lowenstein-Jensen(LJ)培养技术对150例根据病史疑似肺结核患者的痰标本进行了AFB培养。总共收集两个清晨样品用于涂片[Ziehl-Neelsen(ZN)染色]和培养方法。观察到AFB的ZN染色在113例患者中为阳性(75%),而通过LJ培养基进行的AFB培养在66例中(44%)生长。因此,通过LJ培养基对总共66个AFB培养阳性样品进行了AFB药物敏感性测试(DST)。采用耐药比例法分离后,对异烟肼(INH),利福平(RIF),吡嗪酰胺(PZA),乙胺丁醇(EMB)和链霉素(SM)进行了DST。结果:总共66个AFB培养阳性标本,20个(30.3%)病例对所有五种药物均敏感,而46(69.7%)例显示对一种或多种药物有抗药性。其中,对利福平的耐药性最高(80.4%),而对异烟肼,吡嗪酰胺,乙胺丁醇和链霉素的耐药性分别为60%,58.7%,52.1%和63%。还观察到,对所有五种药物的耐药性最高(39.18%)。在52.2%的病例中获得了MDR分离株。文盲,低社会经济地位,结核病的既往史和酗酒与MDR的发生在统计学上具有显着的相关性。结论:本研究中耐药的患病率为69.7%。超过一半的病例是多药耐药的。在这项研究中观察到的最常见的耐药模式是对所有一线药物的耐药性。因此,在开始新病例的过程中,正确地解释和完成治疗对避免社会上未来耐药性的发展非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号